WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+17.78%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$9.17B
AUM Growth
+$646M
(+7.6%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-1.44%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
726
New
146
Increased
136
Reduced
152
Closed
261
Top Buys
| 1 |
TE Connectivity
TEL
|
+$118M |
| 2 |
Ovintiv
OVV
|
+$108M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$106M |
| 4 |
Amazon
AMZN
|
+$86M |
| 5 |
Qorvo
QRVO
|
+$80.1M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$238M |
| 2 |
Electronic Arts
EA
|
+$107M |
| 3 |
Autodesk
ADSK
|
+$95.8M |
| 4 |
Keysight
KEYS
|
+$88.3M |
| 5 |
STMicroelectronics
STM
|
+$82.2M |
Sector Composition
| 1 | Healthcare | 41.58% |
| 2 | Technology | 23.85% |
| 3 | Industrials | 10.4% |
| 4 | Energy | 8.49% |
| 5 | Consumer Discretionary | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEM
376
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
| $1.93M | 0.02% |
48,233
-177,512
| -79% | -$7.12M |
|
377
Flowserve
FLS
$7.28B
| $1.9M | 0.02% |
46,056
-129,061
| -74% | -$5.32M |
|
378
Trade Desk
TTD
$25.6B
| $1.85M | 0.02% |
+25,745
| New | +$1.85M |
|
379
Vita Coco
COCO
$2.18B
| $1.83M | 0.02% |
71,277
-195,472
| -73% | -$5.01M |
|
380
Seres Therapeutics
MCRB
$163M
| $1.81M | 0.02% |
64,514
+54,514
| +545% | +$1.53M |
|
381
The Beauty Health Co
SKIN
$296M
| $1.75M | 0.02% |
+562,903
| New | +$1.75M |
|
|
KLRS
382
Kalaris Therapeutics, Inc. Common Stock
KLRS
$87.5M
| $1.71M | 0.02% |
109,174
+19,319
| +22% | +$302K |
|
383
Coherus Oncology, Inc. Common Stock
CHRS
$159M
| $1.67M | 0.02% |
500,000
| – | – |
|
384
Curtiss-Wright
CW
$18.2B
| $1.66M | 0.02% |
+7,429
| New | +$1.66M |
|
385
Sagimet Biosciences
SGMT
$229M
| $1.63M | 0.02% |
300,169
-2
| -0% | -$11 |
|
386
Broadridge
BR
$29.7B
| $1.6M | 0.02% |
7,781
-12,893
| -62% | -$2.65M |
|
387
Warby Parker
WRBY
$3.26B
| $1.51M | 0.02% |
+106,966
| New | +$1.51M |
|
388
Mineralys Therapeutics
MLYS
$2.99B
| $1.51M | 0.02% |
175,000
| – | – |
|
389
Fate Therapeutics
FATE
$111M
| $1.44M | 0.02% |
+385,364
| New | +$1.44M |
|
390
Jasper Therapeutics
JSPR
$43.1M
| $1.37M | 0.01% |
173,299
-126,701
| -42% | -$1,000K |
|
391
Evolent Health
EVH
$1.16B
| $1.35M | 0.01% |
+40,957
| New | +$1.35M |
|
392
Krispy Kreme
DNUT
$531M
| $1.34M | 0.01% |
88,937
-116,775
| -57% | -$1.76M |
|
|
INZY
393
DELISTED
Inozyme Pharma
INZY
| $1.28M | 0.01% |
+300,000
| New | +$1.28M |
|
394
Eledon Pharmaceuticals
ELDN
$160M
| $1.24M | 0.01% |
689,340
+85,347
| +14% | +$154K |
|
395
Cirrus Logic
CRUS
$6.03B
| $1.23M | 0.01% |
+14,727
| New | +$1.23M |
|
|
CNTA
396
Centessa Pharmaceuticals
CNTA
$2.8B
| $1.12M | 0.01% |
140,856
-69,348
| -33% | -$552K |
|
397
Vertex Pharmaceuticals
VRTX
$101B
| $1.12M | 0.01% |
+2,742
| New | +$1.12M |
|
398
MSCI
MSCI
$44.5B
| $1.07M | 0.01% |
1,889
-193
| -9% | -$109K |
|
399
Prime Medicine
PRME
$734M
| $1.06M | 0.01% |
+120,060
| New | +$1.06M |
|
400
Saia
SAIA
$8.16B
| $1.01M | 0.01% |
+2,307
| New | +$1.01M |
|